Reducing umbilical catheter migration rates by using a novel securement device.

Autor: Perl JR; Stanford Byers Center for Biodesign, Stanford University, Stanford, CA, 94305, USA., Crabtree-Beach T; Division of Neonatology, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA., Olyaei A; Division of Neonatology, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA., Hedges M; Division of Neonatology, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA., Jordan BK; Division of Neonatology, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA., Scottoline B; Division of Neonatology, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA. scottoli@ohsu.edu.
Jazyk: angličtina
Zdroj: Journal of perinatology : official journal of the California Perinatal Association [J Perinatol] 2024 Sep; Vol. 44 (9), pp. 1359-1364. Date of Electronic Publication: 2024 Mar 23.
DOI: 10.1038/s41372-024-01943-1
Abstrakt: Objective: This study evaluates the effectiveness of a novel device, LifeBubble, in reducing umbilical cord catheter (UC) migration and associated complications in neonates.
Study Design: A retrospective review was performed at Oregon Health & Science University's NICU (2019-2021) to compare standard adhesive securement with LifeBubble. The primary outcomes were UC migration, discontinuation due to malposition, and CLABSI incidence. Differences between groups were statistically analyzed and logistic regression used to adjust for potential confounders.
Results: Among 118 neonates (57 LifeBubble, 61 adhesive), LifeBubble significantly reduced migration of any UC > 1 vertebral body (12.3% vs. 55.7%), including UVC migration (5.3% vs. 39.3%) and UAC migration (7.0% vs 23.0%), as well as UVC discontinuation due to malposition (5.6% vs 37.7%). The number needed to treat (NNT) to prevent one instance of UVC discontinuation is 4.
Conclusion: LifeBubble effectively reduces UC migration and premature discontinuation, indicating its potential to enhance neonatal care and safety.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: